Automation
If you have any questions about architecture scope and planning, we can help.
Architecture review before implementation
Implementation scope and rollout planning
Clear next-step recommendation
Manual regulatory submission assembly is a high-stakes operational bottleneck, consuming weeks of expert labor and exposing sponsors to costly errors and delays. This page details the foundational agentic architecture that automates this lifecycle.
Manual compilation of FDA or EMA submission packages from fragmented Veeva Vault, Documentum, and clinical data warehouses is a massive operational tax. Teams spend 40-60% of their time on administrative assembly, formatting, and validation, not scientific strategy. This creates deadline risk, increases resubmission probability due to technical errors, and ties up high-cost medical and regulatory talent in repetitive document logistics instead of higher-value review and response activities.
A custom automation workflow replaces this manual chain with a governed, multi-agent system. Orchestrators in LangGraph or a custom framework trigger specialized agents to retrieve content, validate against CDISC and style rules, and assemble drafts. Human review is embedded at critical quality gates for medical and legal sign-off. The result is a repeatable operating model that cuts compilation time by over 70%, ensures traceability from source to submission, and provides real-time health scoring for program management.
A custom agentic workflow transforms the submission process from a high-risk, labor-intensive bottleneck into a repeatable, data-driven strategic asset. Here’s where the measurable impact comes from.
Manual assembly of eCTD modules from fragmented Veeva Vault, Documentum, and clinical data warehouses is a 6-8 week administrative grind. A custom multi-agent system automates retrieval, validation, and formatting, reducing core compilation time by over 70%. This directly accelerates time-to-file, a critical competitive and financial lever in drug launches.
Up to 50% of first-cycle review delays stem from missing evidence or narrative misalignment with guidance. An AI-driven workflow continuously compares draft content against FDA/EMA guidance libraries using RAG, scoring risks and flagging gaps before submission. This proactive quality layer transforms regulatory strategy from reactive to predictive, significantly improving first-cycle approval odds.
Technical validation failures (broken hyperlinks, non-compliant PDFs) cause immediate portal rejections, delaying review by weeks. An automated validation engine performs continuous, rule-based checks against agency specs, integrating with publishing tools to flag issues early. This turns a last-minute scramble into a scheduled, zero-defect process, protecting submission integrity and timelines.
Adapting a core NDA package for an EU MAA or Japan PMDA submission is a manual, error-prone reformatting exercise. Specialized agents apply jurisdiction-specific templates, document structures, and content variations automatically. This parallelization capability can reduce the time and cost of preparing for multiple health authorities by 40-60%, enabling faster global market access.
Responding to FDA Information Requests (IRs) typically takes 2-3 weeks of manual evidence gathering and drafting. An agentic workflow parses the IR, retrieves relevant data from clinical databases and prior submissions, and drafts a structured response for expert review. This cuts response time to days, maintaining review momentum and preventing costly clock stops.
Beyond automating tasks, the workflow creates a living intelligence system. Agents monitor portals for status updates, scan for new guidance, and track commitments, automatically syncing data into RIM systems like Veeva RIM. This eliminates manual data entry, provides real-time submission health scoring, and gives leadership a data-driven command center for portfolio decisions.
A production-grade architecture for automating the assembly, validation, and transmission of high-stakes regulatory dossiers, connecting fragmented R&D, quality, and document systems into a single, auditable workflow.
This orchestration layer automates the manual, error-prone process of compiling FDA or EMA submission packages from dozens of fragmented sources like Veeva Vault, LIMS, and clinical data warehouses. By deploying specialized agents for retrieval, validation, formatting, and publishing, it reduces administrative burden by 40-60%, cuts compilation cycles from weeks to days, and creates a repeatable operating model. The business value is direct: faster time-to-market, lower operational cost, and stronger compliance posture through full data traceability and automated audit trails.
Implementation integrates with existing RIM and document systems via APIs, using LangGraph or a custom orchestrator to manage state and handoffs between agents. Critical controls include human-in-the-loop checkpoints for medical/regulatory review, rule-based validation against CDISC and ICH templates, and comprehensive observability for tracking document status and agent performance. The architecture is deployed as a containerized microservice layer, enabling phased rollout by submission module (e.g., starting with CSR assembly) to manage risk and demonstrate ROI incrementally before full-scale adoption.
A custom regulatory submission workflow is built as a team of specialized agents, each handling a distinct phase of the lifecycle. This orchestrated system connects fragmented data sources, enforces compliance logic, and automates manual assembly tasks to reduce cycle times by 40-60%.
This agent ingests regulatory intelligence (RI) from EMA/FDA portals and internal project data to build a dynamic submission calendar. It assesses guidance updates, competitor approvals, and internal readiness to forecast risks and assign document dependencies, moving planning from static Gantt charts to a real-time, data-driven orchestration layer.
Connected to Veeva Vault, Documentum, and clinical data warehouses, this agent locates required source documents (protocols, CSRs, datasets) based on the submission plan. It validates version control, extracts relevant sections, and initiates the drafting process for summaries, automating the manual collation that typically consumes weeks of writer and programmer time.
This agent automates the mapping of raw clinical data to CDISC standards (SDTM/ADaM). It executes statistical programming logic, generates derived variables, and runs consistency checks across datasets, tables, and narratives. It flags traceability breaks and data discrepancies preemptively, which are a major source of regulatory questions.
Operating on finalized document drafts, this agent applies complex internal and regional formatting templates (e.g., NDA vs. MAA). It ensures strict adherence to eCTD technical specifications—managing hyperlinks, bookmarks, and metadata—and performs pre-submission validation checks. This eliminates the last-minute, error-prone manual publishing bottleneck.
This agent manages the cross-functional review lifecycle (MLR). It intelligently routes documents to medical, legal, and regulatory reviewers based on content, tracks feedback, reconciles comments, and orchestrates the electronic signature collection process via integrated systems like Veeva eSign, ensuring audit-ready approval trails.
The final-mile agent handles the secure, automated upload of validated eCTD packages to agency portals (FDA ESG, EMA Gateway). It manages authentication, chunks large files, monitors transmission status, and logs confirmations. Post-submission, it polls portals for status updates and parses incoming regulatory questions to trigger response workflows.
A custom regulatory submission workflow is not a monolithic deployment but a phased integration of orchestration logic, specialized agents, and enterprise systems. This blueprint details the staged delivery model that de-risks implementation while delivering compounding operational returns.
Phase 1 establishes the core orchestration layer, typically using LangGraph or a custom state machine, to define the submission process model. This layer ingests triggers from project management tools like Planisware and connects to foundational systems such as Veeva Vault for document retrieval. The initial focus is on automating the assembly of low-risk, high-volume documents (e.g., Forms 1571/1572) to validate the data pipeline and agent logic, delivering immediate administrative savings and building stakeholder confidence for subsequent phases.
Phase 2 expands the agentic layer to handle complex clinical data transformations, integrating with SAS environments and clinical data warehouses to automate SDTM/ADaM dataset creation and CSR table population. Concurrently, the validation and eCTD publishing engine is deployed, incorporating rule-based checks against FDA/EMA specifications. Phase 3 introduces predictive analytics for gap analysis and real-time synchronization with the Regulatory Information Management (RIM) system, culminating in full portal transmission automation. Each phase includes defined approval gates, exception routing to Veeva Vault PromoMats, and observability dashboards to monitor agent performance and data lineage.
Comparison of key operational and financial metrics for a typical global NDA/MAA submission process before and after implementing a custom, agentic automation workflow.
| Metric | Manual Baseline | Custom AI Workflow |
|---|---|---|
End-to-End Submission Cycle Time | 9-12 months | 6-8 months |
Document Compilation & Formatting Labor | ~1,200 person-hours | ~300 person-hours |
Pre-Submission Technical Validation Error Rate | 15-20% rejection risk | <2% rejection risk |
Regulatory Question (RQ) Response Time | 30-45 calendar days | 5-10 calendar days |
Cross-Functional Review Cycle Duration | 4-6 weeks per major version | 1-2 weeks per major version |
Data Traceability Verification Effort | Manual, sample-based | Automated, 100% coverage |
Operational Cost per Major Submission | $2.5M - $4M | $1.5M - $2.2M |
A production-grade automation workflow for regulatory submissions connects fragmented R&D, quality, and document systems into a single, auditable orchestration layer that cuts administrative burden by 40-60%.
This workflow automates the end-to-end compilation, validation, and publishing of high-stakes FDA or EMA submission packages. It eliminates the manual, error-prone labor of collating documents from Veeva Vault, LIMS, and clinical data warehouses, formatting them against regional templates, and managing complex review cycles. The operational upside comes from compressing submission timelines from months to weeks, reducing costly rework due to technical errors, and freeing medical writers and regulatory specialists for higher-value strategic work.
Implementation requires a central orchestrator, like LangGraph, to manage specialized agents for data retrieval, rule-based validation, and document assembly. The architecture must integrate with source systems via APIs or RPA, include mandatory human review gates for medical and legal sign-off, and produce immutable audit trails. Critical controls include real-time submission health scoring, automated technical validation against FDA ESG specs, and exception handling to route discrepancies back to subject matter experts before final lock.
Building a custom AI workflow for regulatory submissions requires navigating data quality, legacy systems, and strict compliance. Here’s how we address common technical and operational concerns in a real-world implementation.
The workflow begins with a dedicated data ingestion and normalization layer. Agents are configured with validation rules specific to CDISC standards (SDTM/ADaM) and business logic to flag missing, inconsistent, or non-compliant data at the point of entry. Exceptions are routed to a dedicated queue for human data managers to review and correct in the source system (e.g., Veeva Vault Clinical, LIMS). This ensures only clean, validated data flows into the assembly pipeline, preventing garbage-in-garbage-out scenarios that delay submissions.
A production-grade automation workflow for regulatory submissions requires robust governance, explicit controls, and a phased rollout strategy to manage risk and ensure operational reliability without disrupting high-stakes deadlines.
Effective governance begins with a centralized control plane, typically built on an orchestration framework like LangGraph or a custom microservice layer. This system enforces role-based access, maintains a complete immutable audit trail of all agent actions and document changes, and integrates with enterprise systems like Veeva RIM for master data management. Approval gates are codified into the workflow logic, ensuring no document progresses from draft to final without mandated medical, legal, and regulatory (MLR) review cycles, preserving the necessary human oversight for scientific and compliance decisions.
Phased rollout is non-negotiable. Start by automating discrete, high-volume tasks like technical validation or SDTM dataset generation, deploying agents as co-pilots to existing teams. This builds trust and surfaces data quality issues early. Subsequent phases can introduce more complex orchestration, such as end-to-end CSR assembly, only after controls are proven. Continuous monitoring via dashboards tracking health scores, exception rates, and cycle time reductions provides the data needed to justify expansion while containing operational risk.
Enabling Efficiency, Speed & Accuracy
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Building a custom regulatory submission automation workflow requires a cross-functional team to translate operational pain into a production-grade agentic architecture. This map outlines the key roles, their responsibilities, and the concrete outcomes they drive.
Define the business rules, approval gates, and submission logic that the workflow must encode. They provide the domain knowledge on health authority requirements (FDA/EMA), document templates, and validation criteria. Their involvement ensures the automation is compliant by design, reducing the risk of technical rejection and enabling a 40-60% reduction in administrative burden for their teams.
Designs the multi-agent orchestration layer using frameworks like LangGraph or CrewAI, specifying agent roles (e.g., Document Retriever, Data Validator, Publishing Agent). They architect the integrations with source systems (Veeva Vault, Documentum, clinical data warehouses) and define the data flows, exception handling, and observability hooks. This role is critical for moving from a concept to a technically credible, scalable build.
Responsible for the practical connectivity between the agentic workflow and the fragmented enterprise landscape. They build secure APIs, configure event triggers from document management systems, and ensure reliable data extraction from sources like LIMS, ERP, and SDTM/ADaM datasets. Their work directly impacts data traceability and integrity, creating the reliable pipelines that automation depends on.
Ensures the automation workflow itself is built under a controlled, validated framework (GxP as required). They define the audit trail requirements, electronic signature workflows (e.g., DocuSign/Veeva eSign integration), and the change control procedures for the system. Their oversight is non-negotiable for creating a defensible, inspection-ready automation layer that regulators will trust.
Owns the implementation roadmap, manages stakeholder alignment, and quantifies the ROI. They map the as-is submission lifecycle, identify the highest-ROI bottlenecks for automation (e.g., eCTD compilation, validation), and sequence the rollout—often starting with a 3-4 week pilot on a discrete module like CSR assembly. They tie technical delivery to business outcomes like cycle time reduction and labor leverage.
Provide continuous feedback during the build and pilot phases. They test the agent-generated drafts, validation reports, and user interfaces, ensuring the workflow reduces their manual toil without creating new friction. Their adoption is the ultimate measure of success, turning a technical system into an operational advantage that accelerates their daily work.
This section outlines the core architectural components and implementation considerations for building a custom, agentic regulatory submission workflow.
A production-grade submission automation architecture is a multi-agent system orchestrated by a central controller. The orchestrator manages state, routes tasks between specialized agents (e.g., for document retrieval, data validation, formatting), and enforces business logic. It integrates with source systems like Veeva Vault, LIMS, and clinical data warehouses via APIs or secure connectors. The implementation begins by mapping the current manual process to a state machine, identifying all human-in-the-loop approval gates, and defining the data contracts between each system and agent. This foundational scoping ensures the workflow is auditable and can handle exceptions gracefully.
Implementation requires a phased rollout, starting with a single document type or submission module. Key controls include version locking for source documents, configurable approval workflows in the orchestration layer, and comprehensive logging of all agent decisions for the audit trail. The system must be designed for zero-downtime updates and include a dashboard for real-time submission health scoring. Partnering with a team experienced in LangGraph for orchestration and enterprise system integration is critical to navigating the technical and regulatory complexities, ensuring the build delivers the targeted 40-60% reduction in administrative burden.
About the author
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
How We Work
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
The first call is a practical review of your use case and the right next step.
